BindingDB logo
myBDB logout

6 articles for Eisai Co., Ltd


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDArticle TitlePublishedDeposition
25139751 Synthesis and structure-activity relationships of novel, potent, orally active hypoxia-inducible factor-1 inhibitors. 22-SEP-2014 02-APR-2016
25589937 Distinct binding mode of multikinase inhibitor lenvatinib revealed by biochemical characterization. 15-JAN-2015 20-MAR-2016
25267004 Design, synthesis, and structure-activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonists. 02-DEC-2014 10-MAR-2016
23062820 Synthesis and structure-activity relationships of 8-substituted-2-aryl-5-alkylaminoquinolines: Potent, orally active corticotropin-releasing factor-1 receptor antagonists. 23-OCT-2012 17-MAY-2013
22683343 Design, synthesis and structure-activity relationships of 5-alkylaminolquinolines as a novel series of CRF1 receptor antagonists. 03-JUL-2012 08-FEB-2013
22871582 Design, synthesis, and structure-activity relationships of a series of 2-Ar-8-methyl-5-alkylaminoquinolines as novel CRF1 receptor antagonists. 20-AUG-2012 08-FEB-2013